Generalized myasthenia gravis (mg)."
Drug research and approvals for generalized myasthenia gravis (mg).": what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 16, 2026, Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: —
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA